HEMATOLOGIC INDICES AS POTENTIAL BIOMARKERS IN URTICARIA: A COMPARATIVE CASE–CONTROL STUDY IN ALBANIAN POPULATION

Authors

  • Eralda Lekli University of Medicine, Faculty of Medicine, Department of Internal Diseases, Tirana, Albania; Salus Hospital Tirana, Department of Allergology, Tirana, Albania Author
  • Mehmet Hoxha University of Medicine, Faculty of Medicine, Department of Internal Diseases, Tirana, Albania; University Hospital Mother Teresa, Service of Allergology, Tirana, Albania Author

DOI:

https://doi.org/10.35120/medisij0503135l

Keywords:

Urticaria, Hematological indices, Neutrophil-to-lymphocyte ratio, Systemic inflammation, Biomarkers

Abstract

Urticaria is primarily a mast cell–mediated inflammatory disorder in which basophils, eosinophils, platelets, and multiple inflammatory mediators contribute to its pathophysiology. Routinely available hemogram-derived inflammatory indices may provide inexpensive and objective measures of systemic inflammatory alterations and may have potential value as biomarkers of disease activity, particularly in chronic urticaria, where disease assessment relies substantially on subjective patient-reported outcomes. Although several hematological ratios and indices have been investigated in urticaria, data from the Albanian population remain limited. This study evaluated selected hematological parameters in hospitalized patients with high disease activity urticaria compared with controls and assessed their associations with C-reactive protein (CRP). This cross-sectional retrospective case-control study included 113 patients hospitalized with diagnosis urticaria at the main tertiary hospital center in Tirana and 398 controls who underwent hemogram testing as part of routine health examinations in private practice. The median age was 50 (32–57) years in the urticaria group and 42 (32–54) years in controls with no statistical difference between groups, while females comprised 83 (73.45%) and 269 (67.59%), respectively. Acute urticaria was diagnosed in 55 (48.67%) patients and chronic urticaria in 58 (51.33). All evaluated hematological parameters differed significantly between patients with urticaria and controls (p < 0.001). Patients with urticaria had statistically significant lower absolute eosinophil, basophil, and lymphocyte counts and PDW (platelet distribution width), while MPV (mean platelet volume) and NLR (neutrophil to lymphocyte ratio) were higher. Undetectable eosinophil and basophil counts were observed in 79 (69.91%) and 99 (87.61%) urticaria patients, respectively.  Spearman’s rank correlation analysis showed that NLR was positively correlated with CRP (ρ = 0.233, p = 0.013) and inversely correlated with eosinophils (ρ = −0.487, p < 0.001) and basophils (ρ = −0.276, p = 0.003). Eosinophils and basophils were moderately positively correlated (ρ = 0.430, p < 0.001), while basophils were inversely correlated with CRP (ρ = −0.230, p = 0.014) and eosinophils with MPV (ρ = −0.1919, p = 0.042). No significant correlations were observed between CRP and eosinophils, MPV, or PDW, or between NLR and MPV or PDW. No significant changes were found between groups of chronic and acute urticaria for studied variables. Hospitalized patients with urticaria demonstrated a distinct hematological profile, particularly increased NLR and MPV and decreased eosinophil, basophil, lymphocyte, and PDW values. The association between NLR and CRP suggests potential relevance as a low-cost marker of systemic inflammation. Further prospective studies are needed to validate these findings in the Albanian population and to determine the potential utility of these hematological indices as markers of urticaria disease activity.

Downloads

Download data is not yet available.

References

mean platelet volume as an inflammatory marker in children with chronic spontaneous urticaria. Allergologia Et Immunopathologia, 43(1), 10–13. https://doi.org/10.1016/j.aller.2013.06.002

Calzari, P., Favale, E. M., Cugno, M., Asero, R., Marzano, A. V., & Ferrucci, S. M. (2025). Predictors of early treatment response to antihistamines and omalizumab in chronic spontaneous urticaria. Frontiers in Allergy, 6, 1728559. https://doi.org/10.3389/falgy.2025.1728559

Di Pino, M., Ruberto, M. F., Costanzo, G., Firinu, D., Piras, M. S., Mura, M. N., Del Giacco, S., Coghe, F., Marongiu, F., & Barcellona, D. (2022). Chronic spontaneous urticaria: A low-grade disseminated intravascular coagulation only partially reversed by Omalizumab. Clinical and Experimental Medicine, 23(2), 495–502. https://doi.org/10.1007/s10238-022-00838-9

Kasperska-Zając, A., Grzanka, A., Jarzab, J., Misiołek, M., Wyszyńska-Chłap, M., Kasperski, J., & Machura, E. (2014). The association between platelet count and acute phase response in chronic spontaneous urticaria. BioMed Research International, 2014, 650913. https://doi.org/10.1155/2014/650913

Kolkhir, P., Altrichter, S., Hawro, T., & Maurer, M. (2018). C‐reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria. Allergy, 73(4), 940–948. https://doi.org/10.1111/all.13352

Kolkhir, P., Church, M. K., Altrichter, S., Skov, P. S., Hawro, T., Frischbutter, S., Metz, M., & Maurer, M. (2020). Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment. The Journal of Allergy and Clinical Immunology. In Practice, 8(1), 318-325.e5. https://doi.org/10.1016/j.jaip.2019.08.025

Kolkhir, P., Giménez-Arnau, A. M., Kulthanan, K., Peter, J., Metz, M., & Maurer, M. (2022). Urticaria. Nature Reviews Disease Primers, 8(1), 61. https://doi.org/10.1038/s41572-022-00389-z

Plavsic, A., Tomic-Spiric, V., Arandjelovic, S., Miskovic, R., Dimitrijevic, M., & Peric-Popadic, A. (2021). Biomarkers of disease activity in patients with chronicspontaneous urticaria. Advances in Dermatology and Allergology, 38(6), 1017–1022. https://doi.org/10.5114/ada.2021.112276

Su Küçük, Ö., & Yücel, M. B. (2026). Clinical and molecular aspects of managing chronic spontaneous urticaria: Identifying endotypes, phenotypes, and determinants of treatment response and resistance. Frontiers in Allergy, 6, 1706705. https://doi.org/10.3389/falgy.2025.1706705

Tan, S., Chen, Z., & Lin, T. (2025). Global, regional, and National burden of urticaria (1990–2021), its potential risk factors, and projections to 2046. BMC Public Health, 25(1), 2709. https://doi.org/10.1186/s12889-025-23321-y

Temizel, K. A., Dursun, P., & Ikizoglu, G. (2026). The effect of omalizumab treatment on inflammatory parameters in urticarial diseases: A retrospective study. Postepy Dermatologii I Alergologii, 43(2), 138–143. https://doi.org/10.5114/ada.2026.161026

Trajkova, V. & Velickova, N. (2022). Association of autoimmune status with ASST, autoimmune and atopic diseases in CSU patients. MEDIS – International Journal of Medical Sciences and Research, 1(3), 1-5. https://doi.org/10.35120/medisij010355t

Yim, J. H., Park, H. J., Cho, S. Y., & Shin, M. K. (2019). Mean Platelet Volume and Mean Platelet Volume/Platelet Count Ratio in Chronic Urticaria. Annals of Dermatology, 31(4), 467. https://doi.org/10.5021/ad.2019.31.4.467

Zuberbier, T., Ansari, Z. A., Abdul Latiff, A. H., Abuzakouk, M. M., Agcaoili‐De Jesus, M. S., Agondi, R. C., Al‐Ahmad, M., Alangari, A. A., Alhameli, H., Alonso Bello, C. D., Alshareef, S., Al‐Tamemi, S., Altrichter, S., Al Wahshi, H., Aquilina, S., Araújo, M., Arnaout, R., Asero, R., Ballmer‐Weber, B., … Giménez‐Arnau, A. M. (2026). The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. Allergy, 81(8), 2582–2632. https://doi.org/10.1111/all.70210

Downloads

Published

2026-09-21

How to Cite

HEMATOLOGIC INDICES AS POTENTIAL BIOMARKERS IN URTICARIA: A COMPARATIVE CASE–CONTROL STUDY IN ALBANIAN POPULATION. (2026). MEDIS – International Journal of Medical Sciences and Research, 5(3), 135-139. https://doi.org/10.35120/medisij0503135l